Inventor · disambiguated record
Hervé Geneste
Also filed as: GENESTE HERVE · GENESTE HERVÉ
58 granted patents·27 pending applications·238 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
85 records- 0193US9273068B2Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10AABBOTT GMBH & CO KG·Filed 2012·Granted Mar 1, 2016·25 cites·44 claims
- 0293US8350055B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2010·Granted Jan 8, 2013·23 cites·8 claims
- 0391US8129389B2Substituted oxindole derivatives, medicaments containing the latter and use thereofLUBISCH WILFRIED·Filed 2006·Granted Mar 6, 2012·19 cites·10 claims
- 0490US8703774B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesNETZ ASTRID·Filed 2008·Granted Apr 22, 2014·11 cites·17 claims
- 0590US7902379B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2004·Granted Mar 8, 2011·27 cites·4 claims
- 0688US8815868B2Substituted oxindole derivatives and their use as vasopressin receptor ligandsNETZ ASTRID·Filed 2007·Granted Aug 26, 2014·8 cites·55 claims
- 0787US8859557B2Substituted oxindole derivatives and their use as vasopressin receptor ligandsNETZ ASTRID·Filed 2012·Granted Oct 14, 2014·7 cites·22 claims
- 0887US8703775B2Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnessesOOST THORSTEN·Filed 2008·Granted Apr 22, 2014·10 cites·14 claims
- 0987US6919342B2Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2004·Granted Jul 19, 2005·17 cites·15 claims
- 1083US9938269B2Inhibitor compounds of phosphodiesterase type 10AGENESTE HERVE·Filed 2012·Granted Apr 10, 2018·7 cites·33 claims
- 1183US9527856B2Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2015·Granted Dec 27, 2016·4 cites·38 claims
- 1283US7951807B2Substituted oxindol derivatives and medicaments containing the sameABBOTT GMBH & CO KG·Filed 2005·Granted May 31, 2011·5 cites·7 claims
- 1380US10556907B2Fused heterocyclic compounds as S1P modulatorsABBVIE INC·Filed 2016·Granted Feb 11, 2020·5 cites·12 claims
- 1478US8664214B2Small molecule potentiators of metabotropic glutamate receptors IBRAJE WILFRIED·Filed 2011·Granted Mar 4, 2014·5 cites·19 claims
- 1578US7105508B1Integrin receptors antagonistsABBOTT GMBH & CO KG·Filed 2000·Granted Sep 12, 2006·15 cites·3 claims
- 1677US9242933B2Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)GENESTE HERVE·Filed 2008·Granted Jan 26, 2016·3 cites·18 claims
- 1776US7320979B2N-[(piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2004·Granted Jan 22, 2008·7 cites·22 claims
- 1875US9790203B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 17, 2017·2 cites·26 claims
- 1975US9200005B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2014·Granted Dec 1, 2015·3 cites·23 claims
- 2074US9388180B2Inhibitor compounds of phosphodiesterase type 10AABBOTT GMBH & CO KG·Filed 2013·Granted Jul 12, 2016·3 cites·37 claims
- 2174US8044079B2Substituted oxindole derivatives, medicaments containing said derivatives and use thereofABBOTT GMBH & CO KG·Filed 2006·Granted Oct 25, 2011·1 cites·17 claims
- 2273US9856220B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 2373US9422264B2Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 23, 2016·1 cites·21 claims
- 2473US8580842B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themLUBISCH WILFRIED·Filed 2010·Granted Nov 12, 2013·2 cites·5 claims
- 2573US7960386B2Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptorABBOTT GMBH & CO KG·Filed 2005·Granted Jun 14, 2011·1 cites·12 claims
- 2673US7125883B1Integrin receptor ligandsABBOTT GMBH & CO KG·Filed 2000·Granted Oct 24, 2006·9 cites·2 claims
- 2771US8314120B2Small molecule potentiators of metabotropic glutamate receptorsBRAJE WILFRIED·Filed 2011·Granted Nov 20, 2012·2 cites·32 claims
- 2871US8202870B2Substituted oxindole derivatives, medicaments containing the latter and use thereofLUBISCH WILFRIED·Filed 2006·Granted Jun 19, 2012·1 cites·5 claims
- 2971US2025296917A1Spiro-cyclic amine derivatives as s1p modulatorsABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 3070US9487505B2Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 8, 2016·1 cites·8 claims
- 3169US9475808B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2015·Granted Oct 25, 2016·1 cites·33 claims
- 3269US9163019B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2014·Granted Oct 20, 2015·1 cites·26 claims
- 3368US8431567B2Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligandsGENESTE HERVE·Filed 2007·Granted Apr 30, 2013·1 cites·22 claims
- 3468US7279468B2Integrin ligandsABBOTT GMBH & CO KG·Filed 2001·Granted Oct 9, 2007·4 cites·16 claims
- 3567US8008488B2Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligandsABBOTT GMBH & CO KG·Filed 2004·Granted Aug 30, 2011·3 cites·20 claims
- 3664US7465744B2Triazole compounds and the therapeutic use thereofABBOTT GMBH & CO KG·Filed 2004·Granted Dec 16, 2008·2 cites·16 claims
- 3763US2014378471A1Substituted oxindole derivatives and their use as vasopressin receptor ligandsABBOTT GMBH & CO KG·Filed 2014·Application pending·0 cites
- 3862US7723384B2Keto lactam compounds and use thereofABBOTT GMBH & CO KG·Filed 2004·Granted May 25, 2010·1 cites·19 claims
- 3959US9403796B2Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnessesABBVIE DEUTSCHLAND·Filed 2014·Granted Aug 2, 2016·0 cites·16 claims
- 4059US2010048536A1Novel Substituted Diaryl Azepine Derivatives as Integrin LigandsGENESTE HERVE·Filed 2009·Application pending·0 cites
- 4159US2007021607A1Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing themABBOTT GMBH & CO KG·Filed 2006·Application pending·0 cites
- 4259US2019135777A1Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptorABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 4355US10308610B2Inhibitor compounds of phosphodiesterase type 10AABBVIE DEUTSCHLAND·Filed 2017·Granted Jun 4, 2019·0 cites·22 claims
- 4455US2007054918A1N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptorBRAJE WILFRIED·Filed 2004·Application pending·0 cites
- 4555US2006159678A1Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapyGENESTE HERVE·Filed 2006·Application pending·0 cites
- 4654US2013116241A1Novel inhibitor compounds of phosphodiesterase type 10aABBOTT GMBH & CO KG·Filed 2012·Application pending·0 cites
- 4754US2013116229A1Novel inhibitor compounds of phosphodiesterase type 10aABBOTT GMBH & CO KG·Filed 2012·Application pending·0 cites
- 4853US2004204422A1N-[(Piperazinyl)hetaryl]arylsulfonamide compoundsABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 4952US9006276B2Substituted oxindole derivatives, medicaments containing said derivatives and use thereofOOST THORSTEN·Filed 2011·Granted Apr 14, 2015·0 cites·2 claims
- 5052US8492540B21,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorBRAJE WILFRIED·Filed 2008·Granted Jul 23, 2013·0 cites·20 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →